Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001085037-09-000430
Filing Date
2009-08-06
Accepted
2009-08-05 19:29:06
Documents
1
Period of Report
2009-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MAY 14, 2009 ORIGINALLY FILED ON JUNE 23, 2009 form8k051409.htm 8-K/A 39754
  Complete submission text file 0001085037-09-000430.txt   41837
Mailing Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000
Business Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000 30-210-603-4026
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 000-51652 | Film No.: 09989576
SIC: 8731 Services-Commercial Physical & Biological Research